ANIP

Ani Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality7/10
  • Growth↑ 8/10
  • Value↓ 4/10
Ani Pharmaceuticals sales and earnings growth
ANIP Growth
Good
  • Revenue Y/Y↑ 33.05%
  • EPS Y/Y↑ 426.19%
  • FCF Y/Y↑ 187.00%
Ani Pharmaceuticals gross and profit margin trends
ANIP Profitability
Great
  • Gross margin ↑ 60.80%
  • EPS margin↓ 9.90%
  • ROIC 5Y↓ 6.10%
Ani Pharmaceuticals net debt vs free cash flow
ANIP Risk
Good
  • Debt / Equity↓ 1.1
  • Debt / FCF↓ 1.6
  • Interest coverage↑ 7.3

Ani Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks